SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Procter & Gamble Co – ‘10-Q’ for 3/31/20 – ‘EX-32.2’

On:  Monday, 4/20/20, at 4:17pm ET   ·   For:  3/31/20   ·   Accession #:  80424-20-38   ·   File #:  1-00434

Previous ‘10-Q’:  ‘10-Q’ on 1/23/20 for 12/31/19   ·   Next:  ‘10-Q’ on 10/20/20 for 9/30/20   ·   Latest:  ‘10-Q’ on 4/19/24 for 3/31/24   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/20/20  Procter & Gamble Co               10-Q        3/31/20   73:8.7M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        FY 1920 Q3 Jfm 10-Q                                 HTML   1.00M 
 2: EX-10.1     Company's Form of Separation Agreement and Release  HTML     63K 
 3: EX-10.2     The Procter & Gamble Company Executive Deferred     HTML     91K 
                Compensation Plan                                                
 4: EX-10.3     The Procter & Gamble Performance Stock Program      HTML     40K 
                Summary                                                          
 5: EX-31.1     Exhibit 31.1 Rule 13A-14(A)/15D-14(A)               HTML     28K 
                Certification Chief Executive Officer                            
 6: EX-31.2     Exhibit 31.1 Rule 13A-14(A)/15D-14(A)               HTML     28K 
                Certification Chief Financialofficer                             
 7: EX-32.1     Section 1350 Certification Chief Executive Officer  HTML     24K 
 8: EX-32.2     Section 1350 Certification-Chief Financial Officer  HTML     24K 
64: R1          Document and Entity Information                     HTML    113K 
30: R2          Consolidated Statements of Earnings                 HTML     82K 
23: R3          Condolidated Statements of Comprehensive Income     HTML     51K 
43: R4          Consolidated Balance Sheets                         HTML    123K 
65: R5          Consolidated Statements of Shareholders' Equity     HTML    128K 
31: R6          Consolidated Statements of Cash Flows               HTML    103K 
24: R7          Basis of Presentation                               HTML     25K 
42: R8          New Accounting Pronouncements and Policies          HTML     28K 
66: R9          Segment Information                                 HTML    143K 
40: R10         Goodwill and Other Intangible Assets                HTML     74K 
20: R11         Earnings Per Share                                  HTML     75K 
53: R12         Share-Based Compensation and Postretirement         HTML     41K 
                Benefits                                                         
60: R13         Risk Management Activities and Fair Value           HTML    102K 
                Measurements                                                     
39: R14         Accumulated Other Comprehensive Income (Loss)       HTML     51K 
19: R15         Restructuring Program                               HTML     72K 
52: R16         Leases                                              HTML     54K 
59: R17         Commitments and Contingencies                       HTML     28K 
41: R18         Acquisition                                         HTML     55K 
18: R19         Segment Reporting (Tables)                          HTML    140K 
46: R20         Goodwill and Other Intangible Assets (Tables)       HTML     68K 
69: R21         Earnings Per Share (Tables)                         HTML     74K 
29: R22         Share-Based Compensation and Postretirement         HTML     39K 
                Benefits (Tables)                                                
22: R23         Risk Management Activities and Fair Value           HTML    105K 
                Measurements (Tables)                                            
45: R24         Accumulated Other Comprehensive Income (Loss)       HTML     50K 
                (Tables)                                                         
68: R25         Restructuring Program (Tables)                      HTML     71K 
28: R26         Leases - Supplemental Balance Sheet (Tables)        HTML     32K 
21: R27         Leases - Future Maturities (Tables)                 HTML     43K 
44: R28         Acquisition - Allocation of Purchase Price          HTML     40K 
                (Tables)                                                         
70: R29         Acquisition - Fair Value of Intangibles (Tables)    HTML     36K 
62: R30         New Accounting Pronouncements and Policies New      HTML     23K 
                Accounting Pronouncements and Policies - Effect of               
                Adoption (Details)                                               
54: R31         Segment Information - Sales (Details)               HTML     53K 
16: R32         Segment Information (Details)                       HTML     50K 
37: R33         Goodwill and Other Intangible Assets - Change in    HTML     46K 
                the Net Carrying Amount of Goodwill by Global                    
                Business Unit (Details)                                          
63: R34         Goodwill and Other Intangible Assets -              HTML     31K 
                Identifiable Intangible Assets (Details)                         
55: R35         Goodwill and Other Intangible Assets - Additional   HTML     37K 
                Information (Details)                                            
17: R36         Goodwill and Other Intangible Assets - Fair Value   HTML     39K 
                Sensitivity (Details)                                            
38: R37         Earnings Per Share (Details)                        HTML     69K 
61: R38         Earnings Per Share - Antidilutive Securities        HTML     28K 
                (Details)                                                        
56: R39         Share-Based Compensation and Postretirement         HTML     36K 
                Benefits (Details)                                               
72: R40         Risk Management Activities and Fair Value           HTML     45K 
                Measurements - Schedule of Derivative Instruments                
                (Details)                                                        
47: R41         Risk Management Activities and Fair Value           HTML     31K 
                Measurements - Derivative Instruments, Effect on                 
                Other Comprehensive Income (Loss) (Details)                      
26: R42         Risk Management Activities and Fair Value           HTML     27K 
                Measurements - Derivative Instruments, Effect on                 
                Other Comprehensive Income (Loss) - Additional                   
                Information (Details)                                            
32: R43         Risk Management Activities and Fair Value           HTML     31K 
                Measurements - Derivative Instruments Gain (Loss)                
                (Details)                                                        
73: R44         Risk Management Activities and Fair Value           HTML     46K 
                Measurements - Additional Information (Details)                  
48: R45         Accumulated Other Comprehensive Income (Loss) -     HTML     65K 
                Changes in Aoci and Reclassification Out of Aoci                 
                (Details)                                                        
27: R46         Restructuring Program - Additional Information      HTML     37K 
                (Details)                                                        
33: R47         Restructuring Program - Restructuring Reserve by    HTML     48K 
                Type of Costs (Details)                                          
71: R48         Restructuring Program - Restructuring Costs Per     HTML     41K 
                Segment (Details)                                                
49: R49         Leases - Supplemental Balance Sheet (Details)       HTML     35K 
51: R50         Leases - Future Maturities (Details)                HTML     65K 
58: R51         Leases Additional Information (Details)             HTML     28K 
36: R52         Commitments and Contingencies - Additional          HTML     32K 
                Information (Details)                                            
14: R53         Acquisition - Allocation of Purchase Price          HTML     60K 
                (Details)                                                        
50: R54         Acquisition Acquisition - Fair Value of             HTML     43K 
                Intangibles (Details)                                            
57: R55         Acquisition - Additional Information (Details)      HTML     49K 
67: XML         IDEA XML File -- Filing Summary                      XML    126K 
34: XML         XBRL Instance -- pg-20200331_htm                     XML   2.43M 
35: EXCEL       IDEA Workbook of Financial Reports                  XLSX     67K 
10: EX-101.CAL  XBRL Calculations -- pg-20200331_cal                 XML    180K 
11: EX-101.DEF  XBRL Definitions -- pg-20200331_def                  XML    673K 
12: EX-101.LAB  XBRL Labels -- pg-20200331_lab                       XML   1.30M 
13: EX-101.PRE  XBRL Presentations -- pg-20200331_pre                XML    827K 
 9: EX-101.SCH  XBRL Schema -- pg-20200331                           XSD    137K 
25: JSON        XBRL Instance as JSON Data -- MetaLinks              286±   428K 
15: ZIP         XBRL Zipped Folder -- 0000080424-20-000038-xbrl      Zip    337K 


‘EX-32.2’   —   Section 1350 Certification-Chief Financial Officer


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

EXHIBIT 32.2
Section 1350 Certifications
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of The Procter & Gamble Company (the “Company”) certifies to his knowledge that:
(1)The Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2020 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.


/s/ JON R. MOELLER
(Jon R. Moeller)
Vice Chairman, Chief Operating Officer and Chief Financial Officer
April 20, 2020
Date
A signed original of this written statement required by Section 906 has been provided to The Procter & Gamble Company and will be retained by The Procter & Gamble Company and furnished to the Securities and Exchange Commission or its staff upon request.



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:4/20/204
For Period end:3/31/20
 List all Filings 


5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/04/23  Procter & Gamble Co.              10-K        6/30/23  105:14M
 8/05/22  Procter & Gamble Co.              10-K        6/30/22  109:15M
 8/06/21  Procter & Gamble Co.              10-K        6/30/21  111:15M
 8/07/20  Procter & Gamble Co.              10-K/A      6/30/20  123:19M
 8/06/20  Procter & Gamble Co.              10-K        6/30/20  123:19M
Top
Filing Submission 0000080424-20-000038   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 7, 5:34:35.2pm ET